Top 38 medical and healthcare startups in Seattle
Jan 09, 2026
|
Like
15
1
Funding: $951.3M
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients. It's deploying a platform that can repair and control genes in cells or replace any cell in the body.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients. It's deploying a platform that can repair and control genes in cells or replace any cell in the body.
2
Funding: $515M
Truveta is a healthcare data platform collaboration with physicians, life science researchers, and others in the healthcare community.
Truveta is a healthcare data platform collaboration with physicians, life science researchers, and others in the healthcare community.
3
Funding: $372.5M
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
4
Funding: $363M
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
5
Funding: $299.3M
98point6 combines deep technology with the expertise of board-certified physicians to provide text-based primary care anytime, anywhere.
98point6 combines deep technology with the expertise of board-certified physicians to provide text-based primary care anytime, anywhere.
6
Funding: $261.3M
Impel NeuroPharma is a medical device company developing a novel drug delivery device that uses direct nose-to-brain delivery.
Impel NeuroPharma is a medical device company developing a novel drug delivery device that uses direct nose-to-brain delivery.
7
Funding: $215M
Tune Therapeutics develops epigenomic controls that dial gene expression up or down to potentially thwart cancers, genetic diseases and aging.
Tune Therapeutics develops epigenomic controls that dial gene expression up or down to potentially thwart cancers, genetic diseases and aging.
8
Funding: $187M
Callio Therapeutics develops next-generation antibody-drug conjugates (ADCs) with multiple payloads. They feature differentiated payload and linker technologies, which enables targeted delivery of drug combinations to tumor cells to maximize therapeutic effects for cancer patients. The company's flagship program is an ADC targeting HER2 breast cancer. Callio is a spinoff of Singapore-based Hummingbird Bioscience, which shares the CEO with Callio.
Callio Therapeutics develops next-generation antibody-drug conjugates (ADCs) with multiple payloads. They feature differentiated payload and linker technologies, which enables targeted delivery of drug combinations to tumor cells to maximize therapeutic effects for cancer patients. The company's flagship program is an ADC targeting HER2 breast cancer. Callio is a spinoff of Singapore-based Hummingbird Bioscience, which shares the CEO with Callio.
9
Funding: $177M
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.
10
Funding: $145M
DexCare provides a Platform-as-a-Service offering to manage health system capacity and demand across all lines of care.
DexCare provides a Platform-as-a-Service offering to manage health system capacity and demand across all lines of care.
11
Funding: $135.6M
Tasso is revolutionizing diagnostics by creating technologies for blood sample collection that place the user at the center of process. Our wearable blood collection system, the HemoLinkTM, is being developed to improve the user experience as well as enable both healthcare consumers and providers with convenient access to reliable laboratory test results.
Tasso is revolutionizing diagnostics by creating technologies for blood sample collection that place the user at the center of process. Our wearable blood collection system, the HemoLinkTM, is being developed to improve the user experience as well as enable both healthcare consumers and providers with convenient access to reliable laboratory test results.
12
Funding: $130.1M
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
13
Funding: $120M
Aurion Biotechnologies is on mission is to cure leading forms of blindness and transform the lives of millions of patients, by developing a platform of advanced therapies to treat ocular diseases.
Aurion Biotechnologies is on mission is to cure leading forms of blindness and transform the lives of millions of patients, by developing a platform of advanced therapies to treat ocular diseases.
14
Funding: $95.5M
Vera Whole Health delivers primary care, acute care, and health coaching via on or near-site clinics.
Vera Whole Health delivers primary care, acute care, and health coaching via on or near-site clinics.
15
Funding: $93M
Bonum Therapeutics technology platform can be used to treat a variety of diseases, including oncology.
Bonum Therapeutics technology platform can be used to treat a variety of diseases, including oncology.
16
Funding: $85.1M
Proprio uses machine learning, computer vision, and augmented reality user interfaces to improve the accuracy and efficiency of surgery.
Proprio uses machine learning, computer vision, and augmented reality user interfaces to improve the accuracy and efficiency of surgery.
17
Funding: $71M
Vilya is a biotechnology company that plans to design novel artificial molecules with customized biologic-like properties that can hit difficult-to-drug therapeutic targets in a broad set of indications.
Vilya is a biotechnology company that plans to design novel artificial molecules with customized biologic-like properties that can hit difficult-to-drug therapeutic targets in a broad set of indications.
18
Funding: $67M
Immunexpress, a molecular diagnostics company, developed a product pipeline to address the unmet clinical needs of sepsis patients, as well as the professional needs of clinicians, payers, and healthcare systems.
Immunexpress, a molecular diagnostics company, developed a product pipeline to address the unmet clinical needs of sepsis patients, as well as the professional needs of clinicians, payers, and healthcare systems.
19
Funding: $56.9M
Xealth enables healthcare teams to order digital content and services as easily as they do medications today.
Xealth enables healthcare teams to order digital content and services as easily as they do medications today.
20
Funding: $56M
Visus Therapeutics is a clinical-stage pharmaceutical company lighting the way to dramatically improve patient lives through the development of differentiated, best-in-class ophthalmic therapies.
Visus Therapeutics is a clinical-stage pharmaceutical company lighting the way to dramatically improve patient lives through the development of differentiated, best-in-class ophthalmic therapies.
21
Funding: $55M
Rippl, a mental health organization, is committed to assisting seniors who suffer from dementia and other neurocognitive disorders.
Rippl, a mental health organization, is committed to assisting seniors who suffer from dementia and other neurocognitive disorders.
22
Funding: $46M
Bardy Diagnostics created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy.
Bardy Diagnostics created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy.
23
Funding: $35M
Inipharm is building on novel insights and applying our chemistry expertise to develop therapies for patients with liver disease.
Inipharm is building on novel insights and applying our chemistry expertise to develop therapies for patients with liver disease.
24
Funding: $32.1M
Oisín Biotechnologies' ground-breaking research and technology is demonstrating that the solution to mitigating the effects of age-related diseases is to address the damage created by the aging process itself.
Oisín Biotechnologies' ground-breaking research and technology is demonstrating that the solution to mitigating the effects of age-related diseases is to address the damage created by the aging process itself.
25
Funding: $30M
Cloud Health Systems provides consultations and other health services to consumers, first focusing on metabolic health and obesity.
Cloud Health Systems provides consultations and other health services to consumers, first focusing on metabolic health and obesity.
26
Funding: $27.8M
Talus Bio is a drug discovery biotech startup that develops drugs targeting undruggable transcription factors using AI.
Talus Bio is a drug discovery biotech startup that develops drugs targeting undruggable transcription factors using AI.
27
Funding: $27M
Motivity provides clinical software solutions through insights, data mining and collection for the ABA and behavioral health industries.
Motivity provides clinical software solutions through insights, data mining and collection for the ABA and behavioral health industries.
28
Funding: $20.4M
Curi Bio is integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics of new therapeutics.
Curi Bio is integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics of new therapeutics.
29
Funding: $120K
Since 1995, Firsthand has been creating interactive Virtual Reality applications for education, training, business, research and therapy. Our services include creative design, application development, immersive displays, and customized turnkey VR hardware systems.
Since 1995, Firsthand has been creating interactive Virtual Reality applications for education, training, business, research and therapy. Our services include creative design, application development, immersive displays, and customized turnkey VR hardware systems.
30
Funding: $16.1M
Kevala provides network and digital services intended for delivering flexibility, connectivity and confidence to healthcare's front line.
Kevala provides network and digital services intended for delivering flexibility, connectivity and confidence to healthcare's front line.
31
Funding: $11M
ApoGen Biotechnologies is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapies eventually fail due to the development of drug resistance.
ApoGen Biotechnologies is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapies eventually fail due to the development of drug resistance.
32
Funding: $8.7M
Save lives and improve health by increasing access to quality healthcare for the most underserved communities.
Save lives and improve health by increasing access to quality healthcare for the most underserved communities.
33
Funding: $7M
TransformativeMed is driving a revolution in health information technology by creating "Smart Health Apps.
TransformativeMed is driving a revolution in health information technology by creating "Smart Health Apps.
35
Funding: $5M
Swizzle Ventures is a venture capital firm that empowers women's health and wealth through pivotal life stages.
Swizzle Ventures is a venture capital firm that empowers women's health and wealth through pivotal life stages.
36
Funding: $4.5M
genneve, a digital health company for women in midlife & menopause. genneve increases accessibility to information, health providers and community for women seeking relief for hormone-driven symptoms like hot flashes, insomnia, anxiety and loss of libido.
genneve, a digital health company for women in midlife & menopause. genneve increases accessibility to information, health providers and community for women seeking relief for hormone-driven symptoms like hot flashes, insomnia, anxiety and loss of libido.
38
Dendreon was a biotechnology company produces immunotherapy for prostate cancer. Its cancer vaccine uses a patient’s own immune cells, which are collected, processed and infused back into the individual through an intravenous infusion that is completed in three cycles.
★
See also:
